Learn More
CERILLIANT™ Methotrexate-D3 Solution, 100 μg/mL in Methanol with 0.01N NaOH, Sold by MilliporeSigma™ Supelco™
Certified reference material
Supplier: MilliporeSigma Supelco M1531ML
Description
An internal standard suitable for therapeutic drug monitoring analyses of methotrexate patient serum samples by LC-MS/MS. Used in the treatment of cancer and autoimmune diseases, methotrexate is an antimetabolite and antifolate drug monitored by clinical labs to ensure patients remain within the drug's therapeutic range. The Snap-N-Spike™ solution format allows laboratories to eliminate weighing operations of hazardous substances such as methotrexate, significantly reducing occupational exposure hazards related to handling of acutely toxic powders, and provides the ability to spike into their matrix of choice just before use.
Specifications
| 67-56-1 , 432545-63-6 | |
| UN 1230 - class 3 - PG 2 - Methanol, solution | |
| 457.46 | |
| 1 mL |
| C20H19N8O5D3 | |
| 100 μg/mL in methanol with 0.01N NaOH | |
| Ampule | |
| 9.7°C (49.5°F) - closed cup |
Safety and Handling
H331-H370
H311
EINECSNumber : 200-659-6
Recommended Storage : -20°C
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
CERILLIANT is a registered trademark of Cerilliant Corporation